Dyslipidemias

• 

  Subject Areas on Research

  • A Cost Analysis of Universal versus Targeted Cholesterol Screening in Pediatrics. 
  • A sex-specific relationship between capillary density and anaerobic threshold. 
  • Aerobic and resistance training effects on energy intake: the STRRIDE-AT/RT study. 
  • Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. 
  • Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. 
  • Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial. 
  • Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients. 
  • Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol. 
  • Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. 
  • Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction). 
  • Behavioral health mediators of the link between posttraumatic stress disorder and dyslipidemia. 
  • Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). 
  • Cardiometabolic Risk Factors among Severely Obese Children and Adolescents in the United States, 1999-2012. 
  • Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. 
  • Cardiovascular complications of diabetic kidney disease. 
  • Cardiovascular health knowledge and preventive practices in people living with HIV in Kenya. 
  • Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov. 
  • Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. 
  • Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations. 
  • Cross-sectional relations of lipid concentrations to left ventricular structural attributes. 
  • Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. 
  • Dietary carbohydrate intake and high-sensitivity C-reactive protein in at-risk women and men. 
  • Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers. 
  • Effect of exercise intensity and volume on persistence of insulin sensitivity during training cessation. 
  • Energy balance and metabolism after cancer treatment. 
  • Ethnic variation in the impact of metabolic syndrome components and chronic kidney disease. 
  • Fibrate use in the United States and Canada. 
  • Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects ≥65 Years. 
  • Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease. 
  • Greater weight loss with increasing age in the weight loss maintenance trial. 
  • Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get with the Guidelines-Stroke 2003 to 2012. 
  • Impact of 5-year weight change on blood pressure: results from the Weight Loss Maintenance trial. 
  • Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey. 
  • Impact of metabolic syndrome on perioperative complication rates after total joint arthroplasty surgery. 
  • Impact of obesity on cardiovascular disease. 
  • Impact of obesity on cardiovascular disease. 
  • Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics. 
  • Inactivity, exercise, and visceral fat. STRRIDE: a randomized, controlled study of exercise intensity and amount. 
  • Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment. 
  • Lifetime risk for developing dyslipidemia: the Framingham Offspring Study. 
  • Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination? 
  • Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA). 
  • Lipids and diabetic retinopathy. 
  • Lipids in high-risk patients presenting with ischemic stroke or transient ischemic attack: are we missing the target? 
  • Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. 
  • Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus. 
  • Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. 
  • Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure: A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya. 
  • Metabolic syndrome and risk of age-related macular degeneration. 
  • Metabolic syndrome components and age-related cataract: the Singapore Malay eye study. 
  • MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection. 
  • Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. 
  • Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021. 
  • Patient perspectives on having multiple versus single prescribers of chronic disease medications: results of a qualitative study in a veteran population. 
  • Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection. 
  • Prescriber Continuity and Disease Control of Older Adults. 
  • Prescriber continuity and medication adherence for complex patients. 
  • Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. 
  • Prevention of future cardiovascular disease in high-risk pediatric patients: a role for lipid lowering therapy? 
  • Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database. 
  • Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and visceral adiposity. 
  • Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study. 
  • Retinal vascular manifestations of metabolic disorders. 
  • Risk factor burden and control at the time of admission in patients with acute myocardial infarction: Results from the NCDR. 
  • Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. 
  • Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database. 
  • Statins in adult patients with HIV: Protocol for a systematic review and network meta-analysis. 
  • Study protocol: Couples Partnering for Lipid Enhancing Strategies (CouPLES) - a randomized, controlled trial. 
  • The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study. 
  • The effects of aerobic, resistance, and combination training on insulin sensitivity and secretion in overweight adults from STRRIDE AT/RT: a randomized trial. 
  • The relationship between the blood pressure responses to exercise following training and detraining periods. 
  • Treatment of hypertension and dyslipidemia or their combination among US managed-care patients. 
  • Weight and Metabolic Outcomes 12 Years after Gastric Bypass. 
  • What Defines a Valuable Investment in Global Health Research? 
• 

  Keywords of People

  • Yancy Jr., William Samuel, Associate Professor of Medicine, Medicine, General Internal Medicine